All stock acquisition rights have been exercised. In the monthly exercise status for October 2026, 217,000 shares were delivered, 2,170 stock acquisition rights were exercised, the exercise ratio to total issued was 12.13%, and there were 0 unexercised rights at month-end.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7957","jir_company_name":"Fujicopian Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-10-14","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/7957-20261014-01.pdf","jir_short_summary":"All stock acquisition rights have been exercised. In the monthly exercise status for October 2026, 217,000 shares were delivered, 2,170 stock acquisition rights were exercised, the exercise ratio to total issued was 12.13%, and there were 0 unexercised rights at month-end.","jir_summary":"### Key Points\nToday, the company announced the completion of exercise of the 2nd series stock acquisition rights allocated to third parties issued on 2025-03-10. As the monthly exercise status, between October 1 and October 14, 2026, 217,000 shares were delivered, 2,170 stock acquisition rights were exercised, and the exercise ratio to total issued was 12.13%. There were 0 unexercised stock acquisition rights at month-end.\n\n### Impact and Outlook\nWith the completion of these exercises, the number of outstanding shares may increase to some extent and the free-float ratio may change. Since there are no remaining unexercised rights, the recent dilution from these stock acquisition rights is likely concluded, and uncertainties related to stock acquisition rights in the capital structure have diminished.","jir_financial_highlights":"Number of shares delivered: 217,000 shares (Unknown)\nNumber of stock acquisition rights exercised: 2,170 units (Unknown)\nExercise ratio to total issued: 12.13% (Unknown)","jir_category":"","jir_hashtags":"#FujicopianCoLtd, #StockAcquisitionRightsExerciseStatus","jir_key_figures":"Number of shares delivered: 217,000 shares\nNumber of stock acquisition rights exercised: 2,170 units\nExercise ratio to total issued: 12.13%","jir_meta_title":"Fujicopian Co., Ltd. Announces Completion of Third-Party Allocated Stock Acquisition Rights Exercise\uff5cOctober 2026","jir_meta_description":"Fujicopian Co., Ltd. discloses completion of exercise for the 2nd series stock acquisition rights allocated to third parties and the October 2026 monthly exercise status: 217,000 shares delivered, 2,170 rights exercised, exercise ratio 12.13%, and 0 unexercised rights.","jir_og_title":"Fujicopian Co., Ltd. Announces Completion of Stock Acquisition Rights Exercise\uff5cOctober 2026","jir_og_description":"Announcement of completion of stock acquisition rights exercise and monthly status: 217,000 shares delivered, 2,170 rights exercised, 12.13% ratio to total issued, and 0 unexercised rights.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":60969,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_buyback","footnotes":""},"sector":[],"importance":[],"class_list":["post-130736","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n